Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Ra Pharmaceuticals Inc (RARX)

$26.22 0.71 (2.78%)

17:55 EDT RARX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $26.22

Market Cap 847.23M

PE Ratio -10.40

EPS -2.52

Volume (Avg. Vol.) 765,800

Day's Range 25.02 - 26.66

52-Week Range 8.27 - 27.68

Dividend & Yield N/A (N/A)

RARX Stock Predictions, Articles, and Ra Pharmaceuticals Inc News

From InvestorPlace
From the Web

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

5 Clinical-Stage Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor May 29, 2018

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.

Best & Worst Performing Small Cap Stocks for June 21, 2019

From StockNews.com Jun 21, 2019

LGCY – LGCY leads the way today as the best performing small cap stock, closing up 80.00%.

3 Promising Gene Therapy Stocks

From Talk Markets May 26, 2019

Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.

Benzinga's Top Upgrades, Downgrades For May 22, 2019

From Benzinga May 22, 2019

Top Upgrades Evercore ISI Group upgraded Legg Mason Inc (NYSE: LM) from Underperform to In-Line. Legg Mason shares rose 3.5 percent to close at $36.89 on Tuesday. Analysts at...

Ra Medical Q1 top line up 80%

From Seeking Alpha May 13, 2019

Ra Medical Systems (NASDAQ:RARX) Q1 results highlights:Revenue: $1.7M (+80%).Net loss: ($14.7M); loss/share: ($1.16).Cash and equivalents at quarter-end: $55.1M.

Ra Pharma inks $100M stock sales deal with Jefferies

From Seeking Alpha May 10, 2019

Ra Pharmaceuticals (NASDAQ:RARX) enters into an agreement with Jefferies LLC for the at-the-market sale of up to $100M of its common stock. Jefferies will earn a 3% commission for its efforts.

Ra Pharmaceuticals beats by $0.04

From Seeking Alpha May 9, 2019

Ra Pharmaceuticals (NASDAQ:RARX): Q1 GAAP EPS of -$0.45 beats by $0.04.Cash and cash equivalents of $191.65MPress Release

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!